Acquiring Company
Alembic Pharmaceuticals
Acquired Company
Utility Therapeutics
Description
Alembic Pharmaceuticals has acquired Utility Therapeutics for $12 million. The acquisition will be completed in a staggered manner based on milestone achievements. Utility Therapeutics specializes in developing treatments for urinary tract infections. This acquisition enhances Alembic's portfolio in the pharmaceutical sector.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed